The global gene synthesis market estimated to grow at a CAGR of 28.7% during the forecast period from 2018 to 2025. The gene synthesis market was valued at USD 2,866.1 Mn in 2017 and is estimated to reach US$ 20,122.3 Mn by 2025.
The increasing investments & funds, especially for the development of a new enzymatic approach to DNA synthesis is expected to propel the growth for the global gene synthesis market. The technology platform, and other related resources are helping the company to accelerate the development of the gene synthesis. Companies have also increased their research and development funds for the enhancement of the gene synthesis. Additionally, in 2016, Twist Bioscience raised its revenue with US$ 61 million for the scale-up and commercial operation of the silicon chip-based high throughput low-cost gene synthesis platform.
Gene synthesis is a technique of synthetic biology which is used to create artificial genes in the laboratory. The technique is used for molecular cloning, creating fusion proteins, or achieving sufficiently high protein expression levels. Compared to traditional molecular cloning techniques, the gene synthesis service is helpful in saving both time and money while offering unparalleled top to bottom customizability.
Growing clinical research is expected to drive the market for gene synthesis over the forecast period
The key players operating in the field of gene synthesis worldwide include Thermo Fisher Scientific Inc, Integrated DNA Technologies, Inc., Twist Bioscience, OriGene Technologies, Inc., BioCat GmbH, GenScript, Eurofins Scientific, Bioneer Corporation, ATUM and GENEWIZ among others.
The gene synthesis market is aimed to describe, define and estimate the forecast for market size of the gene synthesis till 2025. The report strategically analyzes macro and micro-markets to entail the major factors impacting the growth of the global gene synthesis market. The market report for gene synthesis is appropriate to cater the needs and demands of various stakeholders that include pharmaceutical, research institutes, biotechnology and medical companies in the form of research services.
The global gene synthesis market is segmented into product & services, application and end user. The product & services segment is classified as consumables, software and services. On the basis of application, the market is categorized into diagnostics, therapeutics, research & developmental activities and others. Based on the end user segment, the gene synthesis market is segmented into academic & research institutes, diagnostics laboratories, biotech & pharmaceutical companies, and others.
On the basis of end user, the biotech and pharmaceutical companies segment expected to held the fastest growing segment in the forecast period. The growing investments made by companies have grown the pharmaceutical & biotechnology companies segment in the market. For instance, Agilent Technologies Inc. and Lasergen, Inc. have collaborated, Agilent has invested approximately US$80 million in Lasergen, the biotechnology company that comprises of the next-generation sequencing technology. After the investment, Agilent may also acquire the Lasergen in 2018. Furthermore, MedGenome Labs Pvt. Ltd raised US$30 million investment from Sequoia and Sofina SA. Moreover, the growing technological development in the molecular biology boosted the sequencing procedures. Major companies have manufactured and designed advanced NGS technology in last few years. For instance, Pacific Biosciences with Sequel, and Oxford Nanopore with PromethION.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.